Cryo-Cell International, Inc. (CCEL)
USD 6.08
(-6.03%)
USD 6.08
(-6.03%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 22.9 Million USD | 6.3% |
| 2022 | 21.54 Million USD | 8.29% |
| 2021 | 19.89 Million USD | -7.42% |
| 2020 | 21.49 Million USD | -1.33% |
| 2019 | 21.78 Million USD | 5.33% |
| 2018 | 20.67 Million USD | 10.82% |
| 2017 | 18.65 Million USD | 7.53% |
| 2016 | 17.35 Million USD | 12.24% |
| 2015 | 15.46 Million USD | 6.67% |
| 2014 | 14.49 Million USD | 6.01% |
| 2013 | 13.67 Million USD | 4.52% |
| 2012 | 13.08 Million USD | -3.24% |
| 2011 | 13.51 Million USD | 2.93% |
| 2010 | 13.13 Million USD | 11.37% |
| 2009 | 11.79 Million USD | 5.64% |
| 2008 | 11.16 Million USD | 2.73% |
| 2007 | 10.86 Million USD | -2.2% |
| 2006 | 11.11 Million USD | 7.8% |
| 2005 | 10.3 Million USD | 13.94% |
| 2004 | 9.04 Million USD | 83.72% |
| 2003 | 4.92 Million USD | 7.57% |
| 2002 | 4.57 Million USD | 14.67% |
| 2001 | 3.99 Million USD | 211.42% |
| 2000 | 1.28 Million USD | -14.53% |
| 1999 | 1.5 Million USD | 1400.0% |
| 1998 | 100 Thousand USD | -75.0% |
| 1997 | 400 Thousand USD | -83.33% |
| 1996 | 2.4 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 5.69 Million USD | -1.89% |
| 2024 Q2 | 6.01 Million USD | 5.73% |
| 2024 Q3 | 5.94 Million USD | -1.28% |
| 2023 Q2 | 5.62 Million USD | -2.22% |
| 2023 Q1 | 5.75 Million USD | 2.34% |
| 2023 Q4 | 5.8 Million USD | 1.53% |
| 2023 FY | 22.9 Million USD | 6.3% |
| 2023 Q3 | 5.71 Million USD | 1.5% |
| 2022 Q3 | 5.33 Million USD | -1.83% |
| 2022 FY | 21.54 Million USD | 8.29% |
| 2022 Q1 | 5.15 Million USD | 2.71% |
| 2022 Q2 | 5.43 Million USD | 5.36% |
| 2022 Q4 | 5.62 Million USD | 5.49% |
| 2021 Q1 | 4.84 Million USD | -7.25% |
| 2021 Q4 | 5.01 Million USD | -0.5% |
| 2021 Q2 | 4.98 Million USD | 2.77% |
| 2021 FY | 19.89 Million USD | -7.42% |
| 2021 Q3 | 5.04 Million USD | 1.25% |
| 2020 Q4 | 5.22 Million USD | -9.16% |
| 2020 Q2 | 5.39 Million USD | 5.35% |
| 2020 Q1 | 5.11 Million USD | -8.9% |
| 2020 FY | 21.49 Million USD | -1.33% |
| 2020 Q3 | 5.75 Million USD | 6.73% |
| 2019 Q4 | 5.61 Million USD | -0.29% |
| 2019 Q2 | 5.49 Million USD | 9.36% |
| 2019 Q3 | 5.63 Million USD | 2.45% |
| 2019 Q1 | 5.02 Million USD | -15.04% |
| 2019 FY | 21.78 Million USD | 5.33% |
| 2018 Q3 | 5.38 Million USD | 13.41% |
| 2018 FY | 20.67 Million USD | 10.82% |
| 2018 Q4 | 5.91 Million USD | 9.91% |
| 2018 Q2 | 4.74 Million USD | 2.63% |
| 2018 Q1 | 4.62 Million USD | -4.33% |
| 2017 FY | 18.65 Million USD | 7.53% |
| 2017 Q2 | 4.64 Million USD | 9.02% |
| 2017 Q3 | 4.91 Million USD | 5.89% |
| 2017 Q4 | 4.83 Million USD | -1.67% |
| 2017 Q1 | 4.26 Million USD | -3.75% |
| 2016 Q1 | 3.8 Million USD | -12.07% |
| 2016 Q3 | 4.78 Million USD | 10.1% |
| 2016 Q2 | 4.34 Million USD | 14.14% |
| 2016 Q4 | 4.42 Million USD | -7.41% |
| 2016 FY | 17.35 Million USD | 12.24% |
| 2015 Q1 | 3.56 Million USD | -2.66% |
| 2015 Q2 | 3.63 Million USD | 1.88% |
| 2015 Q3 | 3.92 Million USD | 8.03% |
| 2015 FY | 15.46 Million USD | 6.67% |
| 2015 Q4 | 4.32 Million USD | 10.12% |
| 2014 FY | 14.49 Million USD | 6.01% |
| 2014 Q3 | 3.43 Million USD | 1.03% |
| 2014 Q4 | 3.66 Million USD | 6.66% |
| 2014 Q2 | 3.4 Million USD | -14.63% |
| 2014 Q1 | 3.98 Million USD | 17.27% |
| 2013 FY | 13.67 Million USD | 4.52% |
| 2013 Q1 | 3.32 Million USD | -5.08% |
| 2013 Q2 | 3.48 Million USD | 4.92% |
| 2013 Q3 | 3.46 Million USD | -0.41% |
| 2013 Q4 | 3.39 Million USD | -2.02% |
| 2012 Q1 | 3.15 Million USD | -9.86% |
| 2012 FY | 13.08 Million USD | -3.24% |
| 2012 Q4 | 3.49 Million USD | 8.77% |
| 2012 Q3 | 3.21 Million USD | 0.01% |
| 2012 Q2 | 3.21 Million USD | 2.03% |
| 2011 Q1 | 3.31 Million USD | -1.91% |
| 2011 Q3 | 3.21 Million USD | -8.11% |
| 2011 FY | 13.51 Million USD | 2.93% |
| 2011 Q4 | 3.49 Million USD | 8.8% |
| 2011 Q2 | 3.49 Million USD | 5.62% |
| 2010 Q2 | 3.15 Million USD | 0.36% |
| 2010 Q3 | 3.45 Million USD | 9.63% |
| 2010 Q1 | 3.14 Million USD | 5.02% |
| 2010 Q4 | 3.37 Million USD | -2.42% |
| 2010 FY | 13.13 Million USD | 11.37% |
| 2009 Q3 | 2.97 Million USD | -2.87% |
| 2009 Q1 | 2.75 Million USD | 1.63% |
| 2009 Q2 | 3.06 Million USD | 11.3% |
| 2009 Q4 | 2.99 Million USD | 0.52% |
| 2009 FY | 11.79 Million USD | 5.64% |
| 2008 Q4 | 2.71 Million USD | -4.33% |
| 2008 Q1 | 2.72 Million USD | 9.78% |
| 2008 Q2 | 2.89 Million USD | 6.22% |
| 2008 Q3 | 2.83 Million USD | -2.11% |
| 2008 FY | 11.16 Million USD | 2.73% |
| 2007 Q4 | 2.48 Million USD | -13.86% |
| 2007 FY | 10.86 Million USD | -2.2% |
| 2007 Q1 | 2.65 Million USD | -6.61% |
| 2007 Q2 | 2.84 Million USD | 7.01% |
| 2007 Q3 | 2.88 Million USD | 1.3% |
| 2006 Q3 | 2.92 Million USD | 2.24% |
| 2006 Q4 | 2.84 Million USD | -2.61% |
| 2006 Q2 | 2.85 Million USD | 15.11% |
| 2006 Q1 | 2.48 Million USD | -9.75% |
| 2006 FY | 11.11 Million USD | 7.8% |
| 2005 Q1 | 2.41 Million USD | 6.54% |
| 2005 Q2 | 2.46 Million USD | 1.99% |
| 2005 Q4 | 2.75 Million USD | 3.01% |
| 2005 Q3 | 2.67 Million USD | 8.31% |
| 2005 FY | 10.3 Million USD | 13.94% |
| 2004 Q3 | 2.37 Million USD | -3.43% |
| 2004 Q1 | 1.95 Million USD | 9.85% |
| 2004 Q4 | 2.26 Million USD | -4.25% |
| 2004 Q2 | 2.45 Million USD | 25.7% |
| 2004 FY | 9.04 Million USD | 83.72% |
| 2003 Q3 | 1.38 Million USD | 44.16% |
| 2003 FY | 4.92 Million USD | 7.57% |
| 2003 Q1 | 802.99 Thousand USD | -31.05% |
| 2003 Q4 | 1.77 Million USD | 28.46% |
| 2003 Q2 | 959.95 Thousand USD | 19.55% |
| 2002 Q3 | 1.28 Million USD | 6.49% |
| 2002 Q1 | 930.74 Thousand USD | -12.14% |
| 2002 Q2 | 1.2 Million USD | 29.17% |
| 2002 FY | 4.57 Million USD | 14.67% |
| 2002 Q4 | 1.16 Million USD | -9.03% |
| 2001 Q4 | 1.05 Million USD | 10.33% |
| 2001 Q3 | 960.12 Thousand USD | -35.3% |
| 2001 Q2 | 1.48 Million USD | 193.74% |
| 2001 Q1 | 505.17 Thousand USD | 25.21% |
| 2001 FY | 3.99 Million USD | 211.42% |
| 2000 FY | 1.28 Million USD | -14.53% |
| 2000 Q4 | 403.46 Thousand USD | 30.92% |
| 2000 Q3 | 308.17 Thousand USD | -19.69% |
| 2000 Q2 | 383.73 Thousand USD | 46.3% |
| 2000 Q1 | 262.29 Thousand USD | -73.77% |
| 1999 Q2 | 200 Thousand USD | 100.0% |
| 1999 Q1 | 100 Thousand USD | 0.0% |
| 1999 Q4 | 1 Million USD | 400.0% |
| 1999 Q3 | 200 Thousand USD | 0.0% |
| 1999 FY | 1.5 Million USD | 1400.0% |
| 1998 Q2 | 100 Thousand USD | 0.0% |
| 1998 FY | 100 Thousand USD | -75.0% |
| 1998 Q4 | 100 Thousand USD | 0.0% |
| 1998 Q3 | 100 Thousand USD | 0.0% |
| 1998 Q1 | 100 Thousand USD | 0.0% |
| 1997 Q4 | - USD | -100.0% |
| 1997 Q1 | 400 Thousand USD | -33.33% |
| 1997 Q2 | 100 Thousand USD | -75.0% |
| 1997 FY | 400 Thousand USD | -83.33% |
| 1997 Q3 | 100 Thousand USD | 0.0% |
| 1996 Q2 | 700 Thousand USD | 0.0% |
| 1996 Q3 | 700 Thousand USD | 0.0% |
| 1996 Q4 | 600 Thousand USD | -14.29% |
| 1996 FY | 2.4 Million USD | 0.0% |
| 1996 Q1 | 700 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Acadia Healthcare Company, Inc. | 682.6 Million USD | 96.645% |
| Addus HomeCare Corporation | 339.87 Million USD | 93.262% |
| AirSculpt Technologies, Inc. | 121.9 Million USD | 81.214% |
| Amedisys, Inc. | 457.07 Million USD | 94.99% |
| American Oncology Network, Inc. | 66.05 Million USD | 65.331% |
| Astrana Health, Inc. | 214.95 Million USD | 89.346% |
| Aveanna Healthcare Holdings Inc. | 595.43 Million USD | 96.154% |
| IMAC Holdings, Inc. | 3.84 Million USD | -495.055% |
| biote Corp. | 127.48 Million USD | 82.036% |
| Cross Country Healthcare, Inc. | 432.06 Million USD | 94.7% |
| COMPASS Pathways plc | -242.93 Thousand USD | 9526.843% |
| DocGo Inc. | 178.95 Million USD | 87.202% |
| The Ensign Group, Inc. | 590.75 Million USD | 96.123% |
| Healthcare Services Group, Inc. | 251.45 Million USD | 90.892% |
| InnovAge Holding Corp. | 132.06 Million USD | 82.659% |
| Assure Holdings Corp. | -2.19 Million USD | 1143.819% |
| The Joint Corp. | 107.14 Million USD | 78.627% |
| LifeStance Health Group, Inc. | 302.09 Million USD | 92.419% |
| Mobile-health Network Solutions Class A Ordinary Shares | -1.07 Million USD | 2237.031% |
| ModivCare Inc. | 446.95 Million USD | 94.876% |
| NewGenIvf Group Limited | 1.68 Million USD | -1261.731% |
| Novo Integrated Sciences, Inc. | 4.95 Million USD | -362.401% |
| Option Care Health, Inc. | 981.22 Million USD | 97.666% |
| P3 Health Partners Inc. | 31.63 Million USD | 27.607% |
| P3 Health Partners Inc. | 31.63 Million USD | 27.607% |
| The Pennant Group, Inc. | 61.9 Million USD | 63.006% |
| Surgery Partners, Inc. | 529.4 Million USD | 95.674% |
| Syra Health Corp. Class A Common Stock | 1.41 Million USD | -1522.026% |
| Talkspace, Inc. | 74.38 Million USD | 69.21% |
| Talkspace, Inc. | 74.38 Million USD | 69.21% |
| The Oncology Institute, Inc. | 59.57 Million USD | 61.557% |
| The Oncology Institute, Inc. | 59.57 Million USD | 61.557% |